Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
This study will compare the relative bioavailability (rate and extent of absorption) of 500
mg Clarithromycin Tablets with that of 500 mg BIAXIN® Tablets following a single oral dose (1
x 500 mg tablet) in healthy adult subjects under non-fasting conditions.